pLenti.PGK.blast-Renilla_Luciferase Citations (6)

Originally described in: Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress.
Toyama EQ, Herzig S, Courchet J, Lewis TL Jr, Loson OC, Hellberg K, Young NP, Chen H, Polleux F, Chan DC, Shaw RJ Science. 2016 Jan 15;351(6270):275-81. doi: 10.1126/science.aab4138. PubMed Journal

---

Articles Citing pLenti.PGK.blast-Renilla_Luciferase

Articles
Gain-of-function hot spot mutant p53(R248Q) regulation of integrin/FAK/ERK signaling in esophageal squamous cell carcinoma. Yu VZ, So SS, Lung ML. Transl Oncol. 2021 Jan;14(1):100982. doi: 10.1016/j.tranon.2020.100982. Epub 2020 Dec 11. PubMed
Secreted Reporter Assay Enables Quantitative and Longitudinal Monitoring of Neuronal Activity. Santos AC, Chiola S, Yang G, Shcheglovitov A, Park S. eNeuro. 2021 Sep 30;8(5). pii: ENEURO.0518-20.2021. doi: 10.1523/ENEURO.0518-20.2021. Print 2021 Sep-Oct. PubMed
The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation. Flegel J, Shaaban S, Jia ZJ, Schulte B, Lian Y, Krzyzanowski A, Metz M, Schneidewind T, Wesseler F, Flegel A, Reich A, Brause A, Xue G, Zhang M, Dotsch L, Stender ID, Hoffmann JE, Scheel R, Janning P, Rastinejad F, Schade D, Strohmann C, Antonchick AP, Sievers S, Moura-Alves P, Ziegler S, Waldmann H. J Med Chem. 2022 Dec 22;65(24):16268-16289. doi: 10.1021/acs.jmedchem.2c00956. Epub 2022 Dec 2. PubMed
Engineered Extracellular Vesicles with Compound-Induced Cargo Delivery to Solid Tumors. Kim R, Kim JH. Int J Mol Sci. 2023 May 27;24(11):9368. doi: 10.3390/ijms24119368. PubMed
Macrophage-to-endothelial cell crosstalk by the cholesterol metabolite 27HC promotes atherosclerosis in male mice. Yu L, Xu L, Chu H, Peng J, Sacharidou A, Hsieh HH, Weinstock A, Khan S, Ma L, Duran JGB, McDonald J, Nelson ER, Park S, McDonnell DP, Moore KJ, Huang LJ, Fisher EA, Mineo C, Huang L, Shaul PW. Nat Commun. 2023 Jul 25;14(1):4101. doi: 10.1038/s41467-023-39586-z. PubMed
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Lv X, Lu X, Cao J, Luo Q, Ding Y, Peng F, Pataer A, Lu D, Han D, Malmberg E, Chan DW, Wang X, Savage SR, Mao S, Yu J, Peng F, Yan L, Meng H, Maneix L, Han Y, Chen Y, Yao W, Chang EC, Catic A, Lin X, Miles G, Huang P, Sun Z, Burt B, Wang H, Wang J, Yao QC, Zhang B, Roth JA, O'Malley BW, Ellis MJ, Rimawi MF, Ying H, Chen X. Science. 2023 Sep 8;381(6662):eabn4180. doi: 10.1126/science.abn4180. Epub 2023 Sep 8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.